BofA maintained a buy call on Biocon with a target price of Rs 415. The brokerage sees a positive trend in the existing portfolio and earnings catalyst in the next few quarters.Stock's recent underperformance provides an attractive buying opportunity, it said. | Subscribe To Our Free Newsletter |
